Literature DB >> 5556211

Quantitation of bone marrow reticulin--a normal range.

D E Bauermeister.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 5556211     DOI： 10.1093/ajcp/56.1.24

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  33 in total

1.  Successful treatment with imatinib mesylate of a CML patient in megakaryoblastic crisis with severe fibrosis.

Authors:  Yuka Hirose; Hitoshi Kiyoi; Masanori Iwai; Toshiya Yokozawa; Masafumi Ito; Tomoki Naoe
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Simultaneous presence of two hematological malignancies: chronic lymphocytic leukemia and myelofibrosis in a patient.

Authors:  Anshu Palta; Shailja Garg; Sandeep Chauhan; Neelam Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2010-11-18       Impact factor: 0.900

3.  Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment.

Authors:  Magnus Hultdin; Gunnel Sundström; Anders Wahlin; Berith Lundström; Jan Samuelsson; Gunnar Birgegård; Anna Engström-Laurent
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

4.  Suspects in the tale of lupus-associated thrombocytopenia.

Authors:  P D Ziakas; J G Routsias; S Giannouli; A Tasidou; A G Tzioufas; M Voulgarelis
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

5.  Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.

Authors:  Ronan Desmond; Danielle M Townsley; Bogdan Dumitriu; Matthew J Olnes; Phillip Scheinberg; Margaret Bevans; Ankur R Parikh; Kinneret Broder; Katherine R Calvo; Colin O Wu; Neal S Young; Cynthia E Dunbar
Journal:  Blood       Date:  2013-12-17       Impact factor: 22.113

6.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

7.  Bone marrow findings at diagnosis in patients with multisystem langerhans cell histiocytosis.

Authors:  Maria Laura Galluzzo; Jorge Braier; Sergio D Rosenzweig; Maria T Garcia de Dávila; Diego Rosso
Journal:  Pediatr Dev Pathol       Date:  2010 Mar-Apr

8.  The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical study.

Authors:  Zbigniew Rudzki; Tomasz Sacha; Anastazja Stój; Sylwia Czekalska; Małgorzata Wójcik; Aleksander B Skotnicki; Barbara Grabowska; Andrzej Zduńczyk; Krzysztof Okoń; Jerzy Stachura
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

9.  Bone marrow hyaluronan distribution in patients with acute myeloid leukemia.

Authors:  Gunnel Sundström; Inger Marie S Dahl; Magnus Hultdin; Berit Lundström; Anders Wahlin; Anna Engström-Laurent
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

10.  Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up.

Authors:  Waleed Ghanima; Julia Turbiner Geyer; Christina S Lee; Leonardo Boiocchi; Allison A Imahiyerobo; Attilio Orazi; James B Bussel
Journal:  Haematologica       Date:  2014-01-24       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.